Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...

Keytruda plus chemo has been approved for unresectable advanced or metastatic malignant pleural mesothelioma based on ...

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic ...

Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting.

Imfinzi with monalizumab and ceralasertib showed promising long-term benefits in advanced NSCLC, but no other combinations ...

I am still struggling to navigate the intrusive questions of well-meaning strangers 17 years after surviving inflammatory ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of ...

In patients with HR-positive breast cancer who recently gave birth, breastfeeding is OK during a break from receiving hormone ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...

ESMO Congress, an expert explained how Nubeqa may reduce fatigue-related side effects in metastatic hormone-sensitive ...

An artificial intelligence model was shown to predict tumor mutation burden in lung cancer and other diseases.